Bioversys AG (BIOV) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-0.71x
Bioversys AG (BIOV) has a Cash Flow-to-Debt Ratio of -0.71x as of December 2025, meaning its operating cash flow of CHF-21.95 Million could theoretically repay -1% of its total liabilities (CHF30.82 Million) in one year. Explore BIOV operating cash flow to assess how effectively this company generates cash.
CF-to-Debt Ratio
-0.71x
Operating CF / Total Liabilities
Operating Cash Flow
CHF-21.95 Million
CHF
Total Liabilities
CHF30.82 Million
CHF
Data as of
Dec 2025
Most recent filing
Bioversys AG Cash Flow-to-Debt Ratio (2024–2025)
Historical debt coverage capacity for Bioversys AG across 2 annual periods. Also explore Bioversys AG (BIOV) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Bioversys AG (2024–2025)
Year-by-year debt coverage analysis for Bioversys AG. For market capitalisation and broader financial context, see market cap of Bioversys AG.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.71x | CHF-21.95 Million | CHF30.82 Million | ▼ -11.0% |
| 2024 | -0.64x | CHF-15.57 Million | CHF24.27 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.